10,000 Shares in Arbutus Biopharma Corporation (NASDAQ:ABUS) Bought by Cyndeo Wealth Partners LLC
Cyndeo Wealth Partners LLC bought a new position in Arbutus Biopharma Corporation (NASDAQ:ABUS – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 10,000 shares of the biopharmaceutical company’s stock, valued at approximately $35,000. Other hedge funds and other institutional investors have also […]
